Invo Fertility highlights retrospective IVF platelet-rich plasma studies at Midwest Reproductive Symposium 2026

Invo Fertility disclosed retrospective platelet-rich plasma studies in fertility patients, with results already presented at the 2026 Midwest Reproductive Symposium International.

• Data suggested ovarian PRP could improve IVF cycle progress in some poor responders, including enabling retrievals previously cancelled or nonproductive.
• Findings also indicated some patients developed viable embryos following prior poor outcomes, though benefits appeared less consistent in older patients.
• Subendometrial PRP was associated with improved ability to proceed to embryo transfer, with some pregnancies reported in patients with poor endometrial development.
• The company framed the work as early evidence that requires confirmation in larger prospective studies, supporting its strategy to expand adjunctive treatment options.